CAPRCapricor Therapeutics, Inc.
Earnings
When Capricor Therapeutics, Inc. reports, what it reported each quarter, and how the stock took the results.
66 quarters. Jun 30, 2010 to Sep 30, 2026. USD.
Next results · Q4 2026Projected
Mar 11, after the close
Thu, Mar 11, 2027in 114 days
Projected from its last 8 releases. The company has not named the day yet.
- Quarter
- Q4 2026 · Ends about Dec 31, 2026
- 10-K window
- Mar 9 – 31
Read against Q4 2025
The same quarter a year earlier, the figures the next ones will be compared with. Thaler holds no estimates.
- Revenue
- —
- Revenue, change from a year earlier: Q4 2024 −7.9%, Q3 2024 −63.4%, Q2 2024 +1.4%, Q1 2024 +64.3%
- Net income
- -$30.17M
- Net income, change from a year earlier: Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m, Q4 2025 n/m
- EPS
- —
- EPS, change from a year earlier: Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m, Q3 2025 n/m
Latest results
- Revenue
- —
- —
- Net income
- -$42.66M
- N/M
- EPS
- -$0.73
- N/M
Read · nothing to show- Revenue
- —
- —
- Net income
- -$40.73M
- N/M
- EPS
- -$0.70
- N/M
- Revenue
- —
- —
- Net income
- -$33.94M
- N/M
- EPS
- -$0.59
- N/M
- Revenue
- —
- —
- Net income
- -$30.17M
- N/M
- EPS
- —
- —
All quarters
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Move | Source trail |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | ||||||||||
| Q3 2026 | Sep 30, 2026 | Nov 10, 2026 · after-hours | Nov 10, 2026 | 41 d | 10-Q | — | — | -$0.73 | +26.5% | |
| Q2 2026 | Jun 30, 2026 | Aug 13, 2026 · after-hours | Aug 14, 2026 | 45 d | 10-Q | — | — | -$0.70 | +58.0% | |
| Q1 2026 | Mar 31, 2026 | May 12, 2026 · after-hours | May 13, 2026 | 43 d | 10-Q | — | — | -$0.59 | 3.5% | |
| FY 2025 | ||||||||||
| Q4 2025derived | Dec 31, 2025 | Mar 12, 2026 · after-hours | Mar 17, 2026 | 76 d | 10-K | — | — | — | 8.6% | |
| Q3 2025 | Sep 30, 2025 | Nov 10, 2025 · after-hours | Nov 10, 2025 | 41 d | 10-Q | — | — | -$0.54 | +11.1% | |
| Q2 2025 | Jun 30, 2025 | Aug 11, 2025 · after-hours | Aug 11, 2025 | 42 d | 10-Q | — | — | -$0.57 | +2.8% | |
| Q1 2025 | Mar 31, 2025 | May 13, 2025 · after-hours | May 14, 2025 | 44 d | 10-Q | — | — | -$0.53 | +5.1% | |
| FY 2024 | ||||||||||
| Q4 2024derived | Dec 31, 2024 | Mar 19, 2025 · after-hours | Mar 26, 2025 | 85 d | 10-K | $11.13M | −7.9% | — | +17.6% | |
| Q3 2024 | Sep 30, 2024 | Nov 13, 2024 · after-hours | Nov 14, 2024 | 45 d | 10-Q | $2.26M | −63.4% | -$0.38 | +9.3% | |
| Q2 2024 | Jun 30, 2024 | Aug 7, 2024 · after-hours | Aug 8, 2024 | 39 d | 10-Q | $3.97M | +1.4% | -$0.35 | +9.0% | |
| Q1 2024 | Mar 31, 2024 | May 13, 2024 · after-hours | May 14, 2024 | 44 d | 10-Q | $4.91M | +64.3% | -$0.31 | — | |
| FY 2023 | ||||||||||
| Q4 2023derived | Dec 31, 2023 | Feb 29, 2024 · after-hours | Mar 11, 2024 | 71 d | 10-K | $12.09M | — | — | +18.1% | |
| Q3 2023 | Sep 30, 2023 | Nov 14, 2023 · after-hours | Nov 14, 2023 | 45 d | 10-Q | $6.19M | +288.7% | -$0.25 | — | |
| Q2 2023 | Jun 30, 2023 | Aug 7, 2023 · after-hours | Aug 8, 2023 | 39 d | 10-Q | $3.92M | — | -$0.29 | +26.5% | |
| Q1 2023 | Mar 31, 2023 | May 11, 2023 · after-hours | May 12, 2023 | 42 d | 10-Q | $2.99M | — | -$0.31 | 1.9% | |
| FY 2022 | ||||||||||
| Q4 2022derived | Dec 31, 2022 | Mar 15, 2023 · after-hours | Mar 17, 2023 | 76 d | 10-K | — | — | — | — | |
| Q3 2022 | Sep 30, 2022 | Nov 10, 2022 · after-hours | Nov 10, 2022 | 41 d | 10-Q | $1.59M | — | -$0.26 | 7.0% | |
| Q2 2022 | Jun 30, 2022 | Aug 10, 2022 · after-hours | Aug 12, 2022 | 43 d | 10-Q | — | — | -$0.29 | +8.5% | |
| Q1 2022 | Mar 31, 2022 | May 10, 2022 · after-hours | May 11, 2022 | 41 d | 10-Q | — | — | -$0.32 | — | |
| FY 2021 | ||||||||||
| Q4 2021derived | Dec 31, 2021 | Mar 10, 2022 · after-hours | Mar 11, 2022 | 70 d | 10-K | $0.00 | −100.0% | — | 7.0% | |
| Q3 2021 | Sep 30, 2021 | Nov 9, 2021 · after-hours | Nov 12, 2021 | 43 d | 10-Q | $0.00 | −100.0% | -$0.17 | 5.7% | |
| Q2 2021 | Jun 30, 2021 | Aug 12, 2021 · after-hours | Aug 13, 2021 | 44 d | 10-Q | $204.08K | +309.3% | -$0.21 | 8.4% | |
| Q1 2021 | Mar 31, 2021 | May 13, 2021 · after-hours | May 14, 2021 | 44 d | 10-Q | $40.82K | −78.0% | -$0.23 | +9.6% | |
| FY 2020 | ||||||||||
| Q4 2020derived | Dec 31, 2020 | Mar 11, 2021 · after-hours | Mar 15, 2021 | 74 d | 10-K | $57.83K | −74.0% | — | 4.8% | |
| Q3 2020 | Sep 30, 2020 | Nov 9, 2020 · pre-market | Nov 13, 2020 | 44 d | 10-Q | $16.86K | −88.1% | -$0.23 | — | |
| Q2 2020 | Jun 30, 2020 | Aug 6, 2020 · after-hours | Aug 10, 2020 | 41 d | 10-Q | $49.86K | −87.8% | -$0.23 | 23.0% | |
| Q1 2020 | Mar 31, 2020 | May 14, 2020 · after-hours | May 15, 2020 | 45 d | 10-Q | $185.69K | −19.4% | -$0.30 | 8.5% | |
| FY 2019 | ||||||||||
| Q4 2019derived | Dec 31, 2019 | Mar 18, 2020 · after-hours | Mar 27, 2020 | 87 d | 10-K | $222.10K | −65.7% | — | — | |
| Q3 2019 | Sep 30, 2019 | Nov 7, 2019 · after-hours | Nov 8, 2019 | 39 d | 10-Q | $142.07K | −35.2% | -$0.43 | — | |
| Q2 2019 | Jun 30, 2019 | Aug 6, 2019 · after-hours | Aug 8, 2019 | 39 d | 10-Q | $410.35K | +1.6% | -$0.59 | 13.3% | |
| Q1 2019 | Mar 31, 2019 | May 13, 2019 · after-hours | May 14, 2019 | 44 d | 10-Q | $230.50K | −42.4% | -$0.75 | 2.3% | |
| FY 2018 | ||||||||||
| Q4 2018derived | Dec 31, 2018 | Mar 28, 2019 · after-hours | Mar 29, 2019 | 88 d | 10-K | $648.08K | +36.2% | — | 13.0% | |
| Q3 2018 | Sep 30, 2018 | Nov 13, 2018 · after-hours | Nov 14, 2018 | 45 d | 10-Q | $219.25K | −30.0% | -$1.35 | — | |
| Q2 2018 | Jun 30, 2018 | Aug 9, 2018 · after-hours | Aug 13, 2018 | 44 d | 10-Q | $403.96K | −59.5% | -$1.42 | 7.6% | |
| Q1 2018 | Mar 31, 2018 | May 10, 2018 · after-hours | May 14, 2018 | 44 d | 10-Q | $400.07K | −54.6% | -$0.14 | 3.0% | |
| FY 2017 | ||||||||||
| Q4 2017derived | Dec 31, 2017 | Mar 14, 2018 · after-hours | Mar 22, 2018 | 81 d | 10-K | $475.80K | −47.5% | — | +1.7% | |
| Q3 2017 | Sep 30, 2017 | Nov 8, 2017 · after-hours | Nov 14, 2017 | 45 d | 10-Q | $313.27K | −58.1% | -$0.12 | 4.7% | |
| Q2 2017 | Jun 30, 2017 | Aug 10, 2017 · after-hours | Aug 14, 2017 | 45 d | 10-Q | $996.46K | −11.8% | -$0.16 | 1.9% | |
| Q1 2017 | Mar 31, 2017 | — | May 15, 2017 | 45 d | 10-Q | $880.81K | −27.5% | -$0.17 | — | |
| FY 2016 | ||||||||||
| Q4 2016derived | Dec 31, 2016 | — | Mar 16, 2017 | 75 d | 10-K | $906.93K | −19.3% | — | +9.3% | |
| Q3 2016 | Sep 30, 2016 | — | Nov 14, 2016 | 45 d | 10-Q | $746.78K | −43.2% | -$0.29 | — | |
| Q2 2016 | Jun 30, 2016 | — | Aug 15, 2016 | 46 d | 10-Q | $1.13M | −12.5% | -$0.26 | — | |
| Q1 2016 | Mar 31, 2016 | — | May 13, 2016 | 43 d | 10-Q | $1.22M | −32.0% | -$0.26 | — | |
| FY 2015 | ||||||||||
| Q4 2015derived | Dec 31, 2015 | — | Mar 30, 2016 | 90 d | 10-K | $1.12M | −19.9% | — | 2.3% | |
| Q3 2015 | Sep 30, 2015 | — | Nov 13, 2015 | 44 d | 10-Q | $1.31M | +1.0% | -$0.18 | — | |
| Q2 2015 | Jun 30, 2015 | — | Aug 14, 2015 | 45 d | 10-Q | $1.29M | +24.0% | -$0.19 | 2.6% | |
| Q1 2015 | Mar 31, 2015 | — | May 13, 2015 | 43 d | 10-Q | $1.79M | +71.6% | -$0.23 | +7.6% | |
| FY 2014 | ||||||||||
| Q4 2014derived | Dec 31, 2014 | — | Mar 16, 2015 | 75 d | 10-K | $1.40M | — | — | +24.8% | |
| Q3 2014 | Sep 30, 2014 | — | Nov 14, 2014 | 45 d | 10-Q | $1.30M | +1,518.1% | -$0.13 | — | |
| Q2 2014 | Jun 30, 2014 | — | Aug 14, 2014 | 45 d | 10-Q | $1.04M | +449.7% | -$0.13 | 1.2% | |
| Q1 2014 | Mar 31, 2014 | — | May 15, 2014 | 45 d | 10-Q | $1.04M | +346.5% | -$0.10 | 19.3% | |
| FY 2013 | ||||||||||
| Q4 2013derived | Dec 31, 2013 | — | Mar 31, 2014 | 90 d | 10-K | $0.00 | — | — | — | |
| Q3 2013 | Sep 30, 2013 | — | Nov 14, 2013 | 45 d | 10-Q | $80.43K | — | -$0.15 | — | |
| Q2 2013 | Jun 30, 2013 | — | Aug 14, 2013 | 45 d | 10-Q | $189.51K | — | -$0.16 | — | |
| Q1 2013 | Mar 31, 2013 | — | Jun 21, 2013 | 82 d | 10-Q | $233.29K | +19.3% | -$0.14 | — | |
| FY 2012 | ||||||||||
| Q4 2012derived | Dec 31, 2012 | — | Jun 21, 2013 | 172 d | 10-K | $0.00 | — | — | — | |
| Q3 2012 | Sep 30, 2012 | — | Jun 21, 2013 | 264 d | 10-Q | $0.00 | −100.0% | -$0.01 | — | |
| Q2 2012 | Jun 30, 2012 | — | Aug 14, 2012 | 45 d | 10-Q | $0.00 | −100.0% | -$0.01 | — | |
| Q1 2012 | Mar 31, 2012 | — | May 15, 2012 | 45 d | 10-Q | $195.50K | — | -$0.02 | — | |
| FY 2011 | ||||||||||
| Q4 2011derived | Dec 31, 2011 | — | Apr 2, 2012 | 93 d | 10-K | — | — | — | — | |
| Q3 2011 | Sep 30, 2011 | — | Nov 14, 2011 | 45 d | 10-Q | $813.00K | — | -$0.03 | — | |
| Q2 2011 | Jun 30, 2011 | — | Aug 15, 2011 | 46 d | 10-Q | $346.00K | — | -$0.03 | — | |
| Q1 2011 | Mar 31, 2011 | — | May 16, 2011 | 46 d | 10-Q | — | — | -$0.03 | — | |
| FY 2010 | ||||||||||
| Q4 2010derived | Dec 31, 2010 | — | Mar 14, 2011 | 73 d | 10-K | — | — | — | — | |
| Q3 2010 | Sep 30, 2010 | — | Nov 12, 2010 | 43 d | 10-Q | — | — | -$0.05 | — | |
| Q2 2010 | Jun 30, 2010 | — | Aug 16, 2010 | 47 d | 10-Q | — | — | -$0.05 | — | |
Earlier years, FY 2010 to FY 2023The latest three years
Move: the stock from the last close before the release to the first close after it. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Source filings
Provenance
ProvenanceData status and checks
Capricor Therapeutics, Inc. · CIK 1133869 · Engraved from SEC EDGAR